ArticleWorld journal of surgical oncology2026

Omitting axillary lymph node dissection or not? A multicenter, retrospective study for breast cancer patients potentially eligible for abemaciclib since the SENOMAC trial.

Zihao Xu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.